Last updated: 2023/12/09
HOMEPAGE
Last updated: 2023/12/09
Home
AVT Offers
Biopharmaceutical Excipients
Protective Agents (For Biological)
D(+)-Trehalose Dihydrate (For Injection) CAS No.: 6138-23-4
D(+)-Trehalose Dihydrate (For Injection)(Sterile) Cas No.: 6138-23-4 Trehalose For Sale
CAS NO 57 50 1 Sucrose For Sale (For Injection)
Buffer Salts (For Biological)
Tromethamine Tris Buffer CAS NO 77 86 1
HEPES
Tris-HCl
Liposome Excipients
Liposomal Phospholipids
HSPC/Hydrogenated Soy Phosphatidylcholine Cas 92128 87 5
DOTAP
DC-CHOL
1,2 Distearoyl SN Glycero 3 Phosphocholine DSPC
1,2-Di(cis-9-octadecenoyl)-sn-glycero-3-phosphocholine(DOPC)
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine(DPPC)
Dimyristoyl Phosphatidylcholine
Cholesterol (For Liposomes)
Cholesterol HP Cas No.: 57-88-5
Protective Agents (For Liposomes)
D(+)-Trehalose Dihydrate (For Injection) CAS NO 6138 23 4
Sucrose (For Injection) CAS No.: 57-50-1
D(+)-Trehalose Dihydrate (For Injection) (Sterile) CAS No.: 6138-23-4
Sucrose Octasulfate Salt (For Liposomes)
Sucrose Octasulfate Potassium Salt Cas No.: 73264 44 5
Fat Emulsion Excipients
Phospholipids (For Fat Emulsion)
Egg Yolk Lecithin Cas No.: 93685 90 6
Auxiliary Emulsifier (For Fat Emulsion)
Oleic Acid Cas No.: 112-80-1
Lipid nanoparticles（LNPs）
Dlin-MC3-DMA
SM 102 LIPID
ALC-0315
DOTAP
DC-CHOLESTEROL
DSPC
DOPC
DMG-PEG2000
DSG-PEG2000
ALC-0159
CHOL (plant)
DOPE
Sustainability
OEM
Why AVT
Company Profile
AVT Value
Resources
FAQ
Video
Sucrose Conductivity Test Final Version
Sucrose Color Value Detection Final Version
Knowledge Hub
CPhI Barcelona 2023
CPhI China 2023
AVT Successfully Held the Quality Control Forum for Injectable Medical Aesthetic Products
Classification of Excipients for Biological Products And Control of Excipients Limit
Study on Liposome Excipients
Application of DOPC and Cholesterol
Stabilization of MRNA Vaccines by Sucrose (For Injection)
Application Advantage of Sucrose as Lyophilized Protectant
Classification and Characteristics of Fat Emulsion
TRIS Product Introduction (provided by the customer)
Advantages and Precautions of TRIS Buffer
Tris Buffer PH Range and Preparation Method
Moderna: Using TRIS Buffer System Can Improve mRNA Stability
Cholesterol Introduction
Molecular Dynamics Simulations: A Study on the Changes of DLin-MC3-DMA of Various Concentrations in Different Helper Lipids DOPE versus DOPC
Categories of Common Buffer Salts
Development principles for selecting buffering salts
Control of Classification and Limits of Biological Products Manufacturing Excipients
Introduction to the Applications of DOPC and Cholesterol
Research on Liposome Excipients
Advantages of Using Sucrose as Freeze-Drying Protectant
Definition, Functions and Common Types of Buffer Solutions
What Are the Functions of Egg Yolk Lecithin?
Several Considerations in Improving the Stability of mRNA Vaccines through Excipients
Analysis on Pfizer/BioNTech's Use of RNase-free HEPES Buffer in the Manufacturing of COVID-19 Vaccines
Moderna: Using TRIS buffering System to Improve mRNA Stability
Formulations of Listed Drug: Inotuzumab Ozogamicin (Besponsa)
Analysis of Dosage Forms and Components of the Drug Product of 14 Listed ADCs
Listed LNP Drug Formulations and Patent Analysis
Interactions between Lipids and Cholesterol
In-depth Analysis of Moderna's Freeze-Dried mRNA Vaccine in Phase III Clinical Trials
Prescription Sharing of Marketed Medicine: CD22-Targeted ADC Drug Ogaldezuximab Besylate (Besponsa)
What Is Excipients in Pharma?
Several Considerations to Note When Choosing Adjuvants for Injectable Formulations
Research on the Application of Trehalose in Cellular Cryopreservation:Cryopreservation of Adipose-derived Stem Cells
The Prospects of Alginate Freezing in Cell Cryopreservation: Freezing Human Pluripotent Stem Cells with Alginate
Application of Trehalose in Cell Cryopreservation: Cryopreservation of Mouse Testicular Germ Cells
Research on the Application of Trehalose in Cell Cryopreservation: OPC Cryopreservation
LNP-mRNA: Beyond COVID-19 Vaccines
Contact AVT
Last updated: 2023/12/09
HOMEPAGE
Last updated: 2023/12/09